Clinical trial
Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis…
NCT00080938 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00080938 |
|---|---|
| Title | Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer |
| Official title | A Phase II Study of Temozolomide and Radiation Therapy in Patients With Brain Metastasis From Non-small Cell Lung Cancer (NSCLC) |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer, Metastatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Temozolomide, Radiation therapy |
| Enrollment | 26 |
| Start date | Dec 20, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Apr 8, 2004 |
| Last update posted | Jun 29, 2023 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: